Utilization and outcome of thrombolytic therapy for acute ischemic stroke: The St. John Hospital code stroke experience

Journal of Clinical Outcomes Management

Volumn 18, Issue 4, 2011, Pages 165-169

  Salami, Sule ^a   Kolluru, Anuradha ^a   Al Najafi, Saif ^a   Stover, Carrie ^a   Mar, Alice ^a   Szpunar, Susan ^a   Moudgil, Shyam ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASTHMA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; TREATMENT OUTCOME;

EID: 79954491302     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009 Jan 27;119(3):e21-181.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Eng J Med 1995;333:1581-7.
3. Barber PA, Zhang J, Demchuk A, et al. Why are stroke patients excluded from tPA therapy? Neurology 2001;56:1015-20.
4. Smith EE, Abdullah AR, Petkovska I, et al. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005;36:2497-9. (Pubitemid 41566987)
5. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
6. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke; results of the MERCI Trial. Stroke 2005; 36:1432-38. (Pubitemid 40967507)
7. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr; American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-8.
8. Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36:1232-40. (Pubitemid 40798745)
9. Rymer MM, Thrutchley DE. Organizing regional networks to increase acute stroke intervention. Neuro Research 2005;27(1 suppl):99-107.